Year archive

Helix BioPharma Corp. — 2024 filings

All 48 regulatory filings released by Helix BioPharma Corp. (HBP) in 2024, sourced directly from the official regulator.

48 Filings

2024 Period

2024 filings (48)

Filing	Released	Lang
Material change report - English.pdf Regulatory Filings	2024-12-12	English
News release - English.pdf Board/Management Information	2024-12-11	English
News release - English.pdf M&A Activity	2024-12-09	English
News release - English.pdf M&A Activity	2024-12-03	English
News release - English.pdf M&A Activity	2024-11-29	English
Material change report - English.pdf Regulatory Filings	2024-11-21	English
News release - English.pdf Regulatory Filings	2024-11-21	English
Material change report - English.pdf Regulatory Filings	2024-11-15	English
Material change report - English.pdf Board/Management Information	2024-11-15	English
News release - English.pdf Regulatory Filings	2024-11-13	English
News release - English.pdf Regulatory Filings	2024-11-13	English
News release - English.pdf Regulatory Filings	2024-11-13	English
News release - English.pdf Board/Management Information	2024-11-13	English
News release - English.pdf Annual Report	2024-10-25	English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2024-10-25	English
Annual information form - English.pdf Annual Report	2024-10-25	English
52-109F1 - Certification of annual filings - CEO (E).pdf Regulatory Filings	2024-10-25	English
52-109F1 - Certification of annual filings - CFO (E).pdf Regulatory Filings	2024-10-25	English
Annual MD&A - English.pdf Management Reports	2024-10-25	English
Audited annual financial statements – English.pdf Annual Report	2024-10-25	English
Material change report - English.pdf Regulatory Filings	2024-10-03	English
News release - English.pdf Regulatory Filings	2024-10-03	English
Material change report - English.pdf Regulatory Filings	2024-09-10	English
News release - English.pdf Proxy Solicitation & Information Statement	2024-09-10	English
Letter of transmittal - English.pdf Share Issue/Capital Change	2024-08-17	English
Certificate and Articles of Amendment.pdf Share Issue/Capital Change	2024-08-16	English
Material change report - English.pdf Regulatory Filings	2024-08-14	English
News release - English.pdf Capital/Financing Update	2024-08-14	English
52-109F2 - Certification of interim filings - CEO (F).pdf Regulatory Filings	2024-06-14	English
52-109F2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2024-06-14	English
Interim MD&A - English.pdf Merger & Acquisition	2024-06-14	English
Interim financial statements/report – English.pdf Interim / Quarterly Report	2024-06-14	English
News release - English.pdf Report Publication Announcement	2024-05-16	English
52-109F2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2024-05-14	English
52-109F2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2024-05-14	English
Interim MD&A - English.pdf Interim / Quarterly Report	2024-05-14	English
Interim financial statements/report – English.pdf Interim / Quarterly Report	2024-05-14	English
Report of exempt distribution (45-106F1).pdf Regulatory Filings	2024-04-18	English
News release - English.pdf Regulatory Filings	2024-04-13	English
Material change report - English.pdf Capital/Financing Update	2024-04-09	English
News release - English.pdf Capital/Financing Update	2024-04-08	English
News release - English.pdf Regulatory Filings	2024-03-29	English
News release - English.pdf Capital/Financing Update	2024-03-28	English
News release - English.pdf Regulatory Filings	2024-03-15	English
Material change report - English.pdf Regulatory Filings	2024-03-05	English
News release - English.pdf Board/Management Information	2024-02-14	English
Report of voting results.pdf Declaration of Voting Results & Voting Rights Announcements	2024-01-18	English
News release - English.pdf Declaration of Voting Results & Voting Rights Announcements	2024-01-18	English